Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives

Shahinda S.R. Alsayed, Shichun Lun, Alan Payne, William R. Bishai, Hendra Gunosewoyo

Research output: Contribution to journalLetterpeer-review


Several rationally designed isoniazid (INH), pyrazinamide (PZA) and ciprofloxacin (CPF) derivatives were conveniently synthesized and evaluated in vitro against H37Rv Mycobacterium tuberculosis (M. tb) strain. CPF derivative 16 displayed a modest activity (MIC = 16 µg/ml) and was docked into the M. tb DNA gyrase. Isoniazid-pyrazinoic acid (INH-POA) hybrid 21a showed the highest potency in our study (MIC = 2 µg/ml). It also retained its high activity against the other tested M. tb drug-sensitive strain (DS) V4207 (MIC = 4 µg/ml) and demonstrated negligible cytotoxicity against Vero cells (IC50 ≥ 64 µg/ml). Four tested drug-resistant (DR) M. tb strains were refractory to 21a, similar to INH, whilst being sensitive to CPF. Compound 21a was also inactive against two non-tuberculous mycobacterial (NTM) strains, suggesting its selective activity against M. tb. The noteworthy activity of 21a against DS strains and its low cytotoxicity highlight its potential to treat DS M. tb.

Original languageEnglish (US)
Pages (from-to)1137-1150
Number of pages14
JournalChemical Biology and Drug Design
Issue number6
StatePublished - Jun 2021


  • ciprofloxacin
  • hybrid molecules
  • indoleamides
  • isoniazid
  • pyrazinamide
  • tuberculosis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives'. Together they form a unique fingerprint.

Cite this